PHARMACOTHERAPY FOR INFLAMMATORY DISEASES OF THE LUNG WITH DORNASEALPHA
- 作者: Gembitskaya T1, Chermenskiy A1, Gembitskaya T2, Chermensky A2
-
隶属关系:
- Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University
- 期: 卷 20, 编号 3 (2009)
- 页面: 38-42
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115330
- ID: 115330
如何引用文章
详细
作者简介
T Gembitskaya
Email: mukoviscidoz otd@mail.ru
A Chermenskiy
Email: mukoviscidoz otd@mail.ru
T Gembitskaya
Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University; Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University
A Chermensky
Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University; Research Institute of Pulmonology Academician LP. Pavlov Saint PetersburgMedical University
参考
- Волков И.К. Возможности использования дорназы альфа (Пульмозим) в детской пульмонологии // Пульмонология. - 2004; 4: 113-117.
- Симанова Т.В., Ожегов A.M. Эффективность препарата Дорназа альфа у детей и подростков с хроническими воспалительными заболеваниями легких // Consilium medicum; 2008; приложение «Болезни органов дыхания»: 50-53.
- Berge M., Brinkhorst G., Kroon A.A., de Jongste J.С. Dnase treatment in primary ciliary dyskinesia - Assessment by nocturnal pulse oximetry // Pediatr. Pulmonol.-1999; 27: 59-61.
- Boeuf В., Prouix F., Morneau S. et al. Safety of endotracheal rhDNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children // Pediatr. Pulmonol. - 1998; 26:147.
- Boogaard R., Hulsmann A.R., van Veen L. et al. Recombinant human deoxyribonuclease in infants with respiratory syncytial virus bronchiolitis // Chest.-2007;131:788-795.
- Desai M.,Weller P.H..Spencer D.A. Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome // Pediatr. Pulmonol. - 1995; 20: 307-308.
- Durward A., Forte V., Shemie S.D. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus // Crit. Care Med. - 2000; 28: 560-562.
- Hendriks Т., de Hoog M., Lequin M.H. et al. DNase and atelectasis in non-cystic fibrosis pediatric patients // Crit. Care. - 2005; 9: 351-356.
- Kupeli S., Teksam O., Dogru D. et al. Use of recombinant human DNase in a premature infant with recurrent atelectasis // Pediatr. Int. -2003;45:584-586.
- Merkus P.J., de Hoog M., van Gent R. et al. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis // Eur. Respir. J.-2001; 18: 734-737.
- Nasr S.Z., Strouse P.J., Soskolne E. et al. Efficacy of recombinant human deoxyribonuclease lin the hospital management of respiratory syncytialvirus bronchiolitis // Chest. - 2001; 120: 203-208.
- Patel A., Harrison E., Durward A. et al. Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatment// Br. J. Anaesth. - 2000; 84: 505-507.
- Reiter P.D., Townsend S.F., Velasquez R. Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia //J. Perinatal. - 2000; 20: 530-534.
- Riethmueller J., Borth-Bruhns Т., Kumpf M. et al. Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children // Pediatr. Pulmonol. - 2006; 41: 61-66.
- Rogers D.F. Mucoactive drugs for asthma & COPD: any place in therapy? // Expert. Opin. Invest. Drugs. - 2002; 11:15-35.
- Simpson G., Roomes D., Reeves B. Succeful treatment of empyema thoracis with human recombinant deoxyribonuclease // Thorax. - 2003; 58: 363-366.
补充文件
![](/img/style/loading.gif)